Molecular mechanisms of butylated hydroxylanisole-induced toxicity: Induction of apoptosis through direct release of cytochrome c

Molecular Pharmacology

Volumn 58, Issue 2, 2000, Pages 431-437

  Yu, Rong ^a   Mandlekar, Sandhya ^a   Kong, A N Tony ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOLE DERIVATIVE; CYTOCHROME C OXIDASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CYTOTOXICITY; DRUG MECHANISM; ENZYME INDUCTION; ENZYME RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033943875     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.2.431     Document Type: Article

References (37)

1. Alnemri ES (1997) Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases. J Cell Biochem 64:33-42.
2. Ashkenazi A and Dixit VM (1998) Death receptors: Signaling and Modulation. Science (Wash DC) 281:1305-1308.
3. Astill BD, Mills J, Rassett RL, Roundbash RL and Terhaar CJ (1962) Fate of butylated hydroxyanisole in man and dog. Agric Food Chem 10:315-318.
4. Benson AM, Hunkeler MJ and Talalay P (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216-5220.
5. Costantini P, Chernyak BV, Petronilli V and Bernardi P (1996) Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271:6746-6751.
6. Cummings SW and Prough RA (1983) Butylated hydroxyanisole-stimulated NADPH-oxidase activity in rat microsomal fractions. J Biol Chem 258:12315-12319.
7. Eletr S, Williams MA, Watkins T and Keith AD (1974) Perturbation of the dynamics of lipid alkyl chains in membrane systems: Effect on the activity of membrane-bound enzymes. Biochim Blophys Acta 339:190-201.
8. Ellis RE, Yuan JY and Horvitz HR (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698.
9. Green DR and Reed JC (1998) Mitochondria and apoptosis. Science (Wash DC) 281:1309-1312.
10. Ito N, Fukushima S, Hagiwara A, Shibata M and Ogiso T (1983) Carcinogenicity of butylated hydroxyanisole in F344 rats. J Natl Cancer Inst 70:343-352.
11. Jiang S, Cai J, Wallace DC and Jones DP (1999) cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved. J Biol Chem 274:29905-29911.
12. Kahl R (1984) Synthetic antioxidants: Biochemical action and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens. Toxicology 33:185-228.
13. Kahl R, Weinke S and Kappus H (1989) Production of reactive oxygen species due to metabolic activation of butylated hydroxyanisole. Toxicology 59:179-194.
14. Kerr JF, Wyllie AH and Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implication in tissue kinetics. Br J Cancer 26:239-257.
15. Kirlin WG, Cai J, Delong MJ, Patten EJ and Jones DP (1999) Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J Nutr 129:1827-1835.
16. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
17. Moldéus P, Dock L, Cha Y-N, Berggren M and Jernstrom B (1982) Elevation of conjugation of capaity in isolated hepatocytes from BHA-treated mice. Biochem Pharmcol 31:1907-1910.
18. Nakagawa Y, Nakajima K, Moore G and Moldéus P (1994) On the mechanisms of 3-tert-butyl-4-hydroxyanisole- and its metabolites-induced cytotoxicities in isolated rat hepatocytes. Eur J Pharmcolol 270:341-348.
19. Nera EA, Iverson F, Lok E, Armstrong CL, Karpinski K and Clayson DB (1988) A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male fisher 344 rats. Toxicology 53:251-268.
20. Saleh A, Srinivasula SM, Acharya S, Fishel R and Alnemri ES (1999) cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 274:17941-17945.
21. Schilderman PAEL, van Maanen JMS, Sweets EJ, ten Hoor F and Kleinjans JCS (1993) Oxygen radical formation during prostaglandin H synthase-mediated biotransformation of butylated hydroxyanisole. Carcinogenesis 14:347-353.
22. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES and Green DR (1999) Ordering the cytochrome c-initiated caspase cascade:hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281-292.
23. 2+)-ATPaSe of sarcoplasmic reticulum. FEBS Lett 203:121-126.
24. Spector DL (1998) Isolation of mitochondria from cells and tissues. in Cells: A Laboratory Manual (Spector DL, Goldman RD, and Leinwand LA, eds) pp 41.1-41.7, Cold Spring Harbor Laboratory Press, New York.
25. Srinivasula SM, Ahmad M, Fernandes Alnemri T, Litwack G and Alnemri ES (1996) Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 93:14486-14491.
26. Susin SA, Zamzami N, Castedo M, Daugas E, Wang H-G, Geley S, Fassy F, Reed JC and Kroemer G (1997) The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J Exp Med 186:25-37.
27. Thompson C (1995) Apoptosis in the pathogenesis and treatment of disease. Science (Wash DC) 267:1456-1462.
28. Thompson D and Moldéus P (1988) Cytotoxicity of butylated hydroxyanisole and butylated hydroxytoluene in isolated rat hepatocytes. Biochem Pharmacol 37: 2201-2207.
29. Thompson DC, Cha Y-N and Trush MA (1989) The peroxidase-dependent activation of butylated hydroxyanisole and butylated hydroxytoluene (BHT) to reactive intermediates. J Biol Chem 264:3957-3965.
30. Thornberry NA and Lazebnik Y (1998) Caspases: Enemies within. Science (Wash DC) 281:1312-1316.
31. Wattenberg LW (1973) Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. J Natl Cancer Inst 50:1541-1544.
32. Wurzen G and Olsen P (1986) BHA study in pigs. Food Chem Toxicol 24:1229-1233.
33. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP and Wang X (1997) Prevention of apoptosis by Bcl2: Release of cytochrome c from mitochondria blocked. Science (Wash DC) 275:1129-1132.
34. Yu R, Mandlekar S, Harvey KJ, Ucker DS and Kong A-NT (1998) Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 58:402-408.
35. Yu R, Mandlekar S, Lei W, Fahl WE, Tan T-H and Kong A-NT (1999) p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J Biol Chem 275:2322-2372.
36. Yu R, Tan T-H and Kong A-NT (1997) Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J Biol Chem 272:28962-28970.
37. Zou H, Henzel WJ, Lui X, Lutschg A and Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.